Involvement of reactive oxygen species in multidrug resistance of a vincristine-selected lymphoblastoma

Cancer Science

Volumn 98, Issue 8, 2007, Pages 1206-1214

  Tsai, Shih Ying ^a   Sun, Nian Kang ^a   Lu, Hsing Pang ^a   Cheng, Mei ling ^a   Chao, Chuck C K ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BUTHIONINE SULFOXIMINE; CATALASE; CISPLATIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; SCAVENGER; SUPEROXIDE DISMUTASE; VINCRISTINE;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL TYPE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS RESISTANCE; DRUG CYTOTOXICITY; DRUG TARGETING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LYMPHOBLASTOMA; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; LYMPHOMA; REACTIVE OXYGEN SPECIES; VINCRISTINE;

EID: 34347268139     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00513.x     Document Type: Article

References (49)

1. Chang G. Multidrug resistance ABC transporters. FEBS Lett 2003; 555: 102-5.
2. Krishna R, Mayer LD. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci 2000; 11: 265-83.
3. Childs S, Ling V. The MDR superfamily of genes and its biological implications. In: DeVita VT, Hellman S, Rosenberg SA, eds. Important Advances in Oncology. Philadelphia: Lippincott, 1994; 21-36.
4. Chen C, Chin JE, Ueda K et al. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 1986; 47: 381-9.
5. Ling V, Thompson LH. Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J Cell Physiol 1974; 83: 103-16.
6. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, Gottesman MM. P-glycoprotein: from genomics to mechanism. Oncogene 2003; 22: 7468-85.
7. Ho Y, Sheu LF, Ng JA, Hsu SM. Establishment and characterisation of an Epstein-Barr virus negative B immunoblastic lymphoma cell line. Br J Cancer 1990; 61: 655-8.
8. Chao C. Cross-resistance to cis-diamminedichloroplatinum (II) of a multidrug-resistant lymphoma cell line associated with decreased drug accumulation and enhanced DNA repair. Eur J Pharmacol 1996; 305: 213-22.
9. Wyllie A, Ha DE. Cell injury and death. In: McGee J, Isaacson PJ, Wright NA, eds. Oxford Textbook of Pathology. Oxford: Oxford University Press, 1992; 141-152.
10. Lockshin R, Zakeri Z. Caspase-independent cell death? Oncogene 2004; 23: 2766-73.
11. Guenal I, Sidoti-de Fraisse C, Gaumer S, Mignotte B. Bcl-2 and Hsp27 act at different levels to suppress programmed cell death. Oncogene 1997; 15: 347-60.
12. Clement M, Pervaiz S. Reactive oxygen intermediates regulate cellular response to apoptotic stimuli: An hypothesis. Free Radic Res 1999; 30: 247-52.
13. Moghaddas S, Hoppel CL, Lesnefsky EJ. Aging defect at the QO site of complex III augments oxyradical production in rat heart interfibrillar mitochondria. Arch Biochem Biophys 2003; 414: 59-66.
14. Pamplona R, Portero-Otin M, Bellmun MJ, Gredilla R, Barja G. Aging increases Nepsilon-(carboxymethyl) lysine and caloric restriction decreases Nepsilon-(carboxyethyl) lysine and Nepsilon-(malondialdehyde) lysine in rat heart mitochondrial proteins. Free Radic Res 2002; 36: 47-54.
15. Ardies C. Inflammation as cause for scar cancers of the lung. Integr Cancer Ther 2003; 2: 238-46.
16. Barzilai A, Yamamoto K. DNA damage responses to oxidative stress. DNA Repair (Amst) 2004; 3: 1109-15.
17. Boonstra J, Post JA. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 2004; 337: 1-13.
18. Chandra J, Samali A, Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med 2000; 29: 323-33.
19. Fleury C, Mignotte B, Vayssiere JL. Mitochondrial reactive oxygen species in cell death signaling. Biochimie 2002; 84: 131-41.
20. Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer. Biochem J 1996; 313: 17-29.
21. LeBel C, Ischiropoulos H, Bondy SC. Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 1992; 5: 227-31.
22. Carter W, Narayanan PK, Robinson JP. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukoc Biol 1994; 55: 253-8.
23. Sun NK, Kamarajan P, Huang H, Chao CC. Restoration of UV sensitivity in UV-resistant HeLa cells by antisense-mediated depletion of damaged DNA-binding protein 2 (DDB2). FEBS Lett 2002; 512: 168-72.
24. Chao C, Huang SL, Huang HM, Lin-Chao S. Cross-resistance to UV radiation of a cisplatin-resistant human cell line: Overexpression of cellular factors that recognize UV-modified DNA. Mol Cell Biol 1991; 11: 2075-80.
25. Kamarajan P, Sun NK, Sun CL, Chao CC. Apaf-1 overexpression partially overcomes apoptotic resistance in a cisplatin-selected HeLa cell line. FEBS Lett 2001; 505: 206-12.
26. Wyllie A, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984; 142: 67-77.
27. Darzynkiewicz Z, Li X. Measurements of Cell Death by Flow Cytometry. London: Portland Press, 1996.
28. Martin SJ, Reutelingsperger CPM, McGahon AJ et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 1995; 182: 1545-56.
29. Chiu D, Lubin B. Abnormal vitamin E and glutathione peroxidase levels in sickle cell anemia: Evidence for increased susceptibility to lipid peroxidation in.vivo. J Laboratory Clin Med 1979; 94: 542-8.
30. Chiu D, Stults FH, Tappel AL. Purification and properties of rat lung soluble glutathione peroxidase. Biochim Biophys Acta 1976; 445: 558-66.
31. Aebi H. Catalase in.vitro. Methods Enzymol 1984; 105: 121-6.
32. Lakritz J, Plopper CG, Buckpitt AR. Validated high-performance liquid chromatography-electrochemical method for determination of glutathione and glutathione disulfide in small tissue samples. Anal Biochem 1997; 247: 63-8.
33. Smith N, Dunnett M, Mills PC. Simultaneous quantitation of oxidised and reduced glutathione in equine biological fluids by reversed-phase high-performance liquid chromatography using electrochemical detection. J Chromatogr B Biomed Appl 1995; 673: 35-41.
34. Debatin K, Krammer PH. Death receptors in chemotherapy and cancer. Oncogene 2004; 23: 2950-66.
35. Herr I, Debatin KM. Cellular stress response and apoptosis in cancer therapy. Blood 2001; 98: 2603-14.
36. Kim R, Tanabe K, Uchida Y, Emi M, Inoue H, Toge T. Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy. Cancer Chemother Pharmacol 2002; 50: 343-52.
37. Jordan M, Himes RH, Wilson L. Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in.vitro. Cancer Res 1985; 45: 2741-7.
38. Jordan M, Thrower D, Wilson L. Mechanism of inhibition of cell proliferation by Vinca alkaloids. Cancer Res 1991; 51: 2212-22.
39. Groninger E, Meeuwsen-De Boer GJ, De Graaf SS, Kamps WA, De Bont ES. Vincristine induced apoptosis in acute lymphoblastic leukaemia cells: A mitochondrial controlled pathway regulated by reactive oxygen species? Int J Oncol 2002; 21: 1339-45.
40. McCurrach M, Connor TM, Knudson CM, Korsmeyer SJ, Lowe SW. Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc Natl Acad Sci USA 1997; 94: 2345-9.
41. Schmitt C, Rosenthal CT, Lowe SW. Genetic analysis of chemoresistance in primary murine lymphomas. Nat Med 2000; 6: 1029-35.
42. Tohyama Y, Takano T, Yamamura H. B cell responses to oxidative stress. Curr Pharm Des 2004; 10: 835-9.
43. Jang J, Surh YJ. Potentiation of cellular antioxidant capacity by Bcl-2: implications for its antiapoptotic function. Biochem Pharmacol 2003; 66: 1371-9.
44. Miyamoto Y, Koh YH, Park YS et al. Oxidative stress caused by inactivation of glutathione peroxidase and adaptive responses. Biol Chem 2003; 384: 567-74.
45. Paumi CMLBG, Smitherman PK, Townsend AJ, Morrow CS. Role of multidrug resistance protein 1 (MRP1) and glutathione S-transferase A1-1 in alkylating agent resistance. Kinetics of glutathione conjugate formation and efflux govern differential cellular sensitivity to chlorambucil versus melphalan toxicity. J Biol Chem 2000; 276: 7952-6.
46. Zafarullah M, Li WQ, Sylvester J, Ahmad M. Molecular mechanisms of N -acetylcysteine actions. Cell Mol Life Sci 2003; 60: 6-20.
47. Kobrinsky NL, Sjolander DE, Goldenberg JA, Ortmeier TC. Successful treatment of doxorubicin and cisplatin resistant hepatoblastoma in a child with Beckwith-Wiedemann syndrome with high dose acetaminophen and N -acetylcysteine rescue. Pediatr Blood Cancer 2005; 45: 222-5.
48. Akan I, Akan S, Akca H, Savas B, Ozben T. Multidrug resistance-associated protein 1 (MRP1) mediated vincristine resistance: effects of N -acetylcysteine and buthionine sulfoximine. Cancer Cell Int 2005; 5: 22.
49. Aizawa SOK, Kudo T, Asano J, Hayakari M, Tsuchida S. Characterization of cell death induced by ethacrynic acid in a human colon cancer cell line DLD-1 and suppression by N -acetyl- l -cysteine. Cancer Sci 2003; 94: 886-93.